NCT01509313

Brief Summary

Outpatient polyp treatment can be performed in a few different ways but generally involves passing a special type of hysteroscope (3-6 millimetre in diameter) into the womb through which specifically designed miniature operating instruments are passed to remove the polyp(s). At present the most commonly used instruments use an electrical cutting edge. However, a new instrument using a mechanical cutting edge has come to market. In patients having a general anaesthesia the mechanical cutting instrument has been shown to be easier to learn, more effective at completely removing polyps and quicker. However, the instrument is slightly larger, which could potentially cause more discomfort and prolong the procedure in the outpatient setting. Therefore, the investigators want to compare the electrical and mechanical instruments for speed, completeness of polyp removal and patient acceptability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
121

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Jun 2012

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 5, 2012

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 13, 2012

Completed
5 months until next milestone

Study Start

First participant enrolled

June 1, 2012

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2013

Completed
Last Updated

September 16, 2013

Status Verified

September 1, 2013

Enrollment Period

1 year

First QC Date

January 5, 2012

Last Update Submit

September 13, 2013

Conditions

Keywords

endometrial polypsuterine polypsmorcellatorhysteroscopy

Outcome Measures

Primary Outcomes (1)

  • The time taken for polyp removal

    The time taken to remove the polyp will be defined as the time from insertion to removal of vaginal instrumentation post-randomisation

    at the time of surgery (day 1 intraoperatively)

Secondary Outcomes (2)

  • Patient acceptability or pain

    immediately after the surgery (day 1)

  • Completion of polyp removal

    at the time of surgery (day 1 intraoperatively)

Study Arms (2)

Uterine polypectomy using morcellator

EXPERIMENTAL

A new instrument using a mechanical cutting edge has come to market for uterine polypectomy. In patients having a general anaesthesia the mechanical cutting instrument has been shown to be easier to learn, more effective at completely removing polyps and quicker than current techniques. However, the instrument is slightly larger, which could potentially cause more discomfort and prolong the procedure in the outpatient setting.

Device: hysteroscopic morcellator (TruClear)

Electical Resection

ACTIVE COMPARATOR

At present the most commonly used device for removing the uterine polyps in the outpatient setting is by electrical resection. This will provide comparison for the morcellator device being tested

Device: Bipolar Electrical resectoscope (Versapoint)

Interventions

It can be used to treat uterine pathology with a mechanical cutting edge

Also known as: TruClear(Smith&Nephew, USA)
Uterine polypectomy using morcellator

It can be used to treat uterine pathology with an electrical cutting edge

Also known as: Versapoint® (Gynecare; Ethicon Inc., New Jersey, USA).
Electical Resection

Eligibility Criteria

Age16 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Finding of a benign polyp on diagnostic hysteroscopy

You may not qualify if:

  • Need for polypectomy
  • Written informed consent
  • Hysteroscopic features suggesting malignant lesion

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Birmingham Womens Hospital

Birmingham, West Midlands, B15 2TG, United Kingdom

Location

Related Publications (1)

  • Smith PP, Middleton LJ, Connor M, Clark TJ. Hysteroscopic morcellation compared with electrical resection of endometrial polyps: a randomized controlled trial. Obstet Gynecol. 2014 Apr;123(4):745-51. doi: 10.1097/AOG.0000000000000187.

Study Officials

  • Thomas J Clark, MBChB

    Birmingham Womens Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Obstetrics and Gynaecologist

Study Record Dates

First Submitted

January 5, 2012

First Posted

January 13, 2012

Study Start

June 1, 2012

Primary Completion

June 1, 2013

Study Completion

June 1, 2013

Last Updated

September 16, 2013

Record last verified: 2013-09

Locations